These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11261119)

  • 1. Young woman presenting with a strong family history of breast cancer.
    De Prince K
    Lippincotts Prim Care Pract; 2000; 4(4):426-33. PubMed ID: 11261119
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing hereditary breast cancer risk.
    Cancer Pract; 1999; 7(6):279-84. PubMed ID: 10732524
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutation analysis of the breast cancer gene BRCA1 among breast cancer Jordanian females.
    Atoum MF; Al-Kayed SA
    Saudi Med J; 2004 Jan; 25(1):60-3. PubMed ID: 14758382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.
    Cruger DG; Kruse TA; Gerdes AM
    Clin Genet; 2005 Sep; 68(3):228-33. PubMed ID: 16098011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA-analysis in hereditary cancer: the importance of a reliable family history].
    Kapma S; Leschot NJ; Aalfs CM
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):57-60. PubMed ID: 15688834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive oncology and familial breast cancer].
    Pescia G; Perey L
    Rev Med Suisse Romande; 1997 Aug; 117(8):603-6. PubMed ID: 9340715
    [No Abstract]   [Full Text] [Related]  

  • 7. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of gynaecological malignancy.
    Eccles DM
    Br J Hosp Med; 1996 Oct 16-Nov 5; 56(8):416-9. PubMed ID: 8909717
    [No Abstract]   [Full Text] [Related]  

  • 9. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's decisions regarding management of breast cancer risk.
    MacDonald DJ
    Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18. Genetics of breast cancer.
    Irving M; Elmslie F; Berg J
    Int J Clin Pract; 2002 Nov; 56(9):677-82. PubMed ID: 12469982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to the patient with a family history of breast cancer.
    Kirk J; Brennan M; Houssami N; Ung O
    Aust Fam Physician; 2006; 35(1-2):43-7. PubMed ID: 16489386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.
    Keogh LA; Southey MC; Maskiell J; Young MA; Gaff CL; Kirk J; Tucker KM; Rosenthal D; McCredie MR; Giles GG; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2258-63. PubMed ID: 15598789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening younger women with a family history of breast cancer--does early detection improve outcome?
    Maurice A; Evans DG; Shenton A; Ashcroft L; Baildam A; Barr L; Byrne G; Bundred N; Boggis C; Wilson M; Duffy SW; Howell A
    Eur J Cancer; 2006 Jul; 42(10):1385-90. PubMed ID: 16750910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of living with a strong family history of breast cancer.
    Maheu C
    Can J Nurs Res; 2009 Jun; 41(2):100-12. PubMed ID: 19650516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient education. Family history of breast cancer.
    NSW Breast Cancer Institute
    Aust Fam Physician; 2006; 35(1-2):49-50. PubMed ID: 16502546
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives.
    Friedenson B; Friedenson H
    MedGenMed; 2002 Aug; 4(3):3. PubMed ID: 12466746
    [No Abstract]   [Full Text] [Related]  

  • 19. 31-year-old female with a prior breast cancer and strong breast cancer family history who continues to menstruate after chemotherapy.
    Sorscher S
    Clin Adv Hematol Oncol; 2003 Mar; 1(3):184; discussion 184-5. PubMed ID: 16224403
    [No Abstract]   [Full Text] [Related]  

  • 20. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
    Riem L
    MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.